ProShares UltraShort Nasdaq Biotechnology
BIS
#3942
ETF rank
C$2.62 M
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ US
Market
C$15.84
Share price
3.34%
Change (1 day)
12.18%
Change (1 year)

Expense ratio and fees for ProShares UltraShort Nasdaq Biotechnology (BIS)

Expense Ratio

Expense Ratio as of November 2026: 0.95%

Gross Expense Ratio

Gross Expense Ratio as of November 2026: 3.91%

Net Expense Ratio

Net Expense Ratio as of November 2026: 0.95%